Clinical Trial Update: Pharmacological Effects of Crushing Prasugrel in STEMI Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates the pharmacological effects of crushing prasugrel tablets in patients with ST-elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• St-elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-12-28